Latest Reports
Marine Pharmaceutical Excipients Market Size, Share, Opportunities, And Trends By Coverage (Agar, Alginate, Carrageenan, Others), By Formulation (Capsule, Liquid, Others), By Distribution Channel (Online, Offline), And By Geography - Forecasts From 2024 To 2029
The marine pharmaceutical excipients market is projected to grow at a steady rate during the forecast period. Derived from marine organisms, particularly marine algae, inactive ingredients have emerged as pivotal components in the formulat...
India Anti-Rheumatic Drug Market Size, Share, Opportunities, And Trends By Type Of Disease (Osteoarthritis, Rheumatoid Arthritis, Gout, Lupus, Others), By Drug Class (Disease-modifying Anti-Rheumatic Drugs (DMARDs), Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, JAK Inhibitor, Others), And By Sales Channel (Prescription, Over-the-counter (OTC)) - Forecasts From 2023 To 2028
The Indian anti-rheumatic drugs market is estimated to grow at a CAGR of 5.01%, reaching US$6423.254 million in 2028 from US$4561.441 million in 2021. Indian anti-rheumatic drugs market is growing due to the rising rheumatoid arthritis prev...
Spain Anti-Rheumatic Drug Market Size, Share, Opportunities, And Trends By Type Of Disease (Osteoarthritis, Rheumatoid Arthritis, Gout, Lupus, Others), By Drug Class (Disease-modifying Anti-Rheumatic Drugs (DMARDs), Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, JAK Inhibitor, Others), And By Sales Channel (Prescription, Over-the-counter (OTC)) - Forecasts From 2023 To 2028
The Spain antirheumatic drug market is expected to grow at a compound annual growth rate of 2.12% over the forecast period to reach a market size of US$4,011.904 million in 2028, from US$3,463.331 million in 2021. Anti-rheumatic drugs are ...
South Africa Anti-Rheumatic Drug Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type of Disease (Osteoarthritis, Rheumatoid Arthritis, Gout, Lupus, Others), By Type of Molecule (Pharmaceuticals, Biopharmaceuticals) And By Type (Prescription, Over-the-counter (OTC)) - Forecasts From 2022 To 2027
South Africa antirheumatic drugs market was valued at US$2,176.81 million in 2020 and is forecasted to grow owing to the high prevalence of chronic disease across the country. The market in South Africa is projected to grow at a notable CA...
Indonesia Anti-Rheumatic Drug Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type of Disease (Osteoarthritis, Rheumatoid Arthritis, Gout, Lupus, Others), By Type of Molecule (Pharmaceuticals, Biopharmaceuticals) And By Sales Channel (Prescription, Over-the-counter (OTC)) - Forecasts From 2022 To 2027
Indonesia antirheumatic drugs market was valued at US$3,543.837 million in 2020. The market is projected to grow at a CAGR of 3.00% to attain a value of US$4,359.458 million by 2027. The market for antirheumatic drugs in Indonesia is proj...
China Anti-Rheumatic Drug Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type of Disease (Osteoarthritis, Rheumatoid Arthritis, Gout, Lupus, Others), By Type of Molecule (Pharmaceuticals, Biopharmaceuticals) And By Sales Channel (Prescription, Over-the-counter (OTC)) - Forecasts From 2022 To 2027
China antirheumatic drugs market was valued at US$19.081 billion in 2020. The market is projected to grow at a CAGR of 3.73% to attain a value of US$24.654 billion by 2027. A growing number of patients suffering from arthritis in China is ...
Asia Pacific (APAC) Anti-Rheumatic Drug Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type of Disease (Osteoarthritis, Rheumatoid Arthritis, Gout, Lupus, Others), By Type of Molecule (Pharmaceuticals, Biopharmaceuticals), By Type (Prescription, Over-the-counter (OTC)), And By Country - Forecasts From 2022 To 2027
Asia Pacific (APAC) antirheumatic drugs market was evaluated at US$48.438 billion for the year 2020, growing at a CAGR of 3.37% reaching the market size of US$61.086 billion by the year 2027. The rapidly growing number of patients sufferin...
Europe Anti-Rheumatic Drug Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type of Disease (Osteoarthritis, Rheumatoid Arthritis, Gout, Lupus, Others), By Type of Molecule (Pharmaceuticals, Biopharmaceuticals), By Type (Prescription, Over-the-counter (OTC)), And By Country - Forecasts From 2022 To 2027
European antirheumatic drugs market is estimated grow with a CAGR of 2.87% over the forecast period to attain a market size of US$51,553.83 million in 2027, from US$42,299.989 million in 2020. The antirheumatic drugs market in the European...
Myanmar Anti-Rheumatic Drug Market Size, Share, COVID-19 Impact, Opportunities And Trends By Type of Disease (Osteoarthritis, Rheumatoid Arthritis, Gout, Lupus, Others), By Type of Molecule (Pharmaceuticals, Biopharmaceuticals) And By Type (Prescription, Over-the-counter (OTC)) - Forecasts From 2022 To 2027
Myanmar antirheumatic drugs market was valued at US$718.219 million in 2020 and is projected to grow during the forecast period. The significant prevalence of overweight and obesity in Myanmar is causing a rise in the number of people suf...
Nigeria Anti-Rheumatic Drug Market Size, Share, COVID-19 Impact, Opportunities And Trends By Type of Disease (Osteoarthritis, Rheumatoid Arthritis, Gout, Lupus, Others), By Type of Molecule (Pharmaceuticals, Biopharmaceuticals), And By Type (Prescription, Over-the-counter (OTC)) - Forecasts From 2022 To 2027
Nigeria antirheumatic drugs market was valued at US$822.216 million in 2020 and is forecasted to grow in the coming years as well. The primary factors driving the demand for numerous antirheumatic drugs in the country include the rising p...
Japan Anti-Rheumatic Drug Market Size, Share, COVID-19 Impact, Opportunities, And Trends By Type Of Disease (Osteoarthritis, Rheumatoid Arthritis, Gout, Lupus, Others), By Drug Class (Disease-modifying Anti-Rheumatic Drugs (DMARDs), Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, JAK Inhibitor, Others), And By Sales Channel (Prescription, Over-the-counter (OTC)) - Forecasts From 2022 To 2027
Japan’s antirheumatic drug market was valued at US$15,757.740 million in 2020. The market is projected to grow at a CAGR of 3.99% to attain a value of US$20,723.660 million by 2027. The market’s growth is being majorly driven by...
Mexico Anti-Rheumatic Drug Market Size, Share, COVID-19 Impact, Opportunities, And Trends By Type Of Disease (Osteoarthritis, Rheumatoid Arthritis, Gout, Lupus, Others), By Drug Class (Disease-modifying Anti-Rheumatic Drugs (DMARDs), Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, JAK Inhibitor, Others), And By Sales Channel (Prescription, Over-the-counter (OTC)) - Forecasts From 2022 To 2027
The Mexican antirheumatic drugs market was valued at US$6,326.779 million in 2020. The market is projected to grow at a CAGR of 2.12% to attain a value of US$7,327.540 million by 2027. The rising Mexican population suffering from arthritis ...
Related Intelligence Hubs
Explore interconnected markets and cross-industry research.